Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Diabetes news

Show

From To
HIV has a similar impact to diabetes on heart disease risk

Living with HIV carries the same lifetime risk of cardiovascular disease as having diabetes, even after taking into account smoking, a US study has estimated.

Published
21 June 2017
By
Keith Alcorn
Curing hepatitis C reduces the risk of diabetes & kidney failure in people with HIV/HCV co-infection

Curing hepatitis C infection substantially reduces the risk of developing type 2 diabetes in people with HIV/hepatitis C virus (HCV) co-infection, but does not reduce

Published
01 February 2017
By
Keith Alcorn
HCV eradication in HIV coinfected patients linked to reduced diabetes, chronic renal failure

Eradication of hepatitis C virus infection among patients coinfected with HIV was associated with reductions in diabetes and chronic renal failure in addition to reduced mortality, HIV progression and liver-related events, according to the results of a Spanish cohort study. These findings led investigators to conclude that HIV coinfected patients should receive HCV therapy regardless of their fibrosis stage.

Published
31 January 2017
From
Healio
People with HIV more likely to develop diabetes, study finds

A new study suggests the diabetes prevalence is much higher among HIV-positive individuals than the general population, even when obesity is not present.

Published
31 January 2017
From
HIV / AIDS News From Medical News Today
People with HIV/HCV co-infection at increased risk of kidney disease and bone disorders

Hepatitis C virus (HCV) infection in people with HIV co-infection is associated with an increased risk of liver disease and liver-related death and also several important non-liver related

Published
02 January 2017
By
Michael Carter
African Americans taking ART have high incidence of illness associated with risk of cardiovascular disease

Black HIV-positive men and women receiving antiretroviral therapy (ART) have especially high rates of health problems that can increase the long-term risk of cardiovascular disease, investigators from the

Published
20 December 2016
By
Michael Carter
Co-morbidities are common and rising among people with HIV in the US

People living with HIV are increasingly experiencing a range of non-AIDS-related co-morbidities as the population ages, including cardiovascular disease, kidney impairment and bone loss leading to fractures,

Published
19 December 2016
By
Liz Highleyman
Managing non-communicable diseases among people living with HIV

Non-communicable diseases (NCDs) – including cardiovascular diseases, diabetes, cancers, and other illnesses – will represent a significant challenge for HIV care in low- and middle-income countries as

Published
13 September 2016
By
Theo Smart
Statins reduce risk of progression to cirrhosis in people with HIV/HCV co-infection

Treatment with statins decreases the risk of progression to liver cirrhosis in people with HIV and hepatitis C virus (HCV) co-infection, investigators from the United States report

Published
06 September 2016
By
Michael Carter
Fatty liver may contribute to higher risk of death for HIV/HCV co-infected people

About a quarter of people in a New York City cohort who had HIV and hepatitis C virus (HCV) died over a ten-year period – a "strikingly

Published
26 August 2015
By
Liz Highleyman

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.